Informações de Cryoport Inc

Mais detalhes de Cryoport Inc Empresa

Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.



Código da empresaCYRX

Nome da EmpresaCryoport Inc

Data de listagemJul 24, 2015

CEOMr. Jerrell Wilson (Jerry) Shelton

Número de funcionários1090

Tipo de títulosOrdinary Share

Fim do ano fiscalJul 24

Endereço112 Westwood Place, Suite 350

CidadeBRENTWOOD

Bolsa de valoresNASDAQ Capital Market Consolidated

PaísUnited States of America

Código postal37027

Telefone19492321900

Sitehttps://www.cryoport.com/

Código da empresaCYRX

Data de listagemJul 24, 2015

CEOMr. Jerrell Wilson (Jerry) Shelton

Executivos da empresa Cryoport Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jerrell Wilson (Jerry) Shelton

Chairman of the Board, President, Chief Executive Officer

1.00M

+2.56%

Mr. Daniel M. (Dan) Hancock

Independent Director

45.86K

+102.52%

Ms. Linda Baddour

Independent Director

44.90K

+107.03%

Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

Independent Director

38.43K

+186.15%

Mr. Mark Sawicki

Senior Vice President, Chief Scientific Officer

--

Dr. Ramkumar Mandalam, Ph.D.

Independent Director

--

Mr. Robert S. Stefanovich

Chief Financial Officer, Senior Vice President, Chief Administrative Officer

--

Mr. Ram M. Jagannath

Independent Director

--

Mr. Scott Eckstein

Investor Relations

--

Mr. Edward J. Zecchini

Senior Vice President, Chief Digital and Technology Officer

--

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Jerrell Wilson (Jerry) Shelton

Chairman of the Board, President, Chief Executive Officer

1.00M

+2.56%

Mr. Daniel M. (Dan) Hancock

Independent Director

45.86K

+102.52%

Ms. Linda Baddour

Independent Director

44.90K

+107.03%

Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

Independent Director

38.43K

+186.15%

Mr. Mark Sawicki

Senior Vice President, Chief Scientific Officer

--

Dr. Ramkumar Mandalam, Ph.D.

Independent Director

--

Detalhamento da receita

Moeda: USDAtualizado em: dom, 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

BioLogistics solutions

18.53M

45.15%

Life Science products

18.18M

44.29%

BioStorage/Bioservices

4.33M

10.56%

Por RegiãoUSD

Nome

Receita

Proporção

Americas

32.20M

78.45%

Europe & Middle East & Africa (EMEA)

5.58M

13.60%

Asia Pacific

3.27M

7.96%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

BioLogistics solutions

18.53M

45.15%

Life Science products

18.18M

44.29%

BioStorage/Bioservices

4.33M

10.56%

Distribuição de ações

Atualizado em: qui, 15 de mai

Investidores

Tipos de investidores

Investidores

Proporção

Cadian Capital Management LP

9.93%

Morgan Stanley & Co. LLC

9.08%

Brown Capital Management, LLC

7.59%

BlackRock Institutional Trust Company, N.A.

6.80%

The Vanguard Group, Inc.

5.57%

Outro

61.03%

Investidores

Proporção

Cadian Capital Management LP

9.93%

Morgan Stanley & Co. LLC

9.08%

Brown Capital Management, LLC

7.59%

BlackRock Institutional Trust Company, N.A.

6.80%

The Vanguard Group, Inc.

5.57%

Outro

61.03%

Tipos de investidores

Investidores

Proporção

Investment Advisor

41.49%

Investment Advisor/Hedge Fund

24.43%

Hedge Fund

19.45%

Research Firm

10.44%

Individual Investor

4.01%

Pension Fund

2.44%

Private Equity

1.24%

Bank and Trust

0.68%

Sovereign Wealth Fund

0.43%

Participação acionária institucional



Atualizado em: ter, 1 de jul

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q2

394

50.37M

100.47%

-14.50M

2025Q1

409

50.98M

101.73%

-14.79M

2024Q4

407

51.87M

104.93%

-14.28M

2024Q3

422

52.00M

105.24%

-13.61M

2024Q2

423

53.55M

108.72%

-9.95M

2024Q1

437

55.31M

112.51%

-7.56M

2023Q4

468

54.03M

110.37%

-6.18M

2023Q3

482

49.41M

101.04%

-7.52M

2023Q2

492

49.81M

109.19%

-5.40M

2023Q1

500

48.02M

99.15%

-8.43M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

Cadian Capital Management LP

4.98M

9.94%

+55.00K

+1.12%

Mar 31, 2025

Morgan Stanley & Co. LLC

4.61M

9.19%

-2.84K

-0.06%

Mar 31, 2025

Brown Capital Management, LLC

4.05M

8.09%

-405.16K

-9.09%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.25M

6.49%

+229.97K

+7.61%

Mar 31, 2025

The Vanguard Group, Inc.

2.75M

5.48%

+13.24K

+0.48%

Mar 31, 2025

Millennium Management LLC

3.36M

6.71%

-778.06K

-18.79%

Mar 31, 2025

Fred Alger Management, LLC

2.53M

5.05%

-34.58K

-1.35%

Mar 31, 2025

Natixis Investment Managers SA

1.70M

3.39%

-15.64K

-0.91%

Mar 31, 2025

Thematics Asset Management SAS

617.20K

1.23%

-131.80K

-17.60%

Jun 30, 2024

Geode Capital Management, L.L.C.

1.12M

2.23%

+21.35K

+1.95%

Mar 31, 2025

Ver Mais

ETFs Relacionados



Nome

Proporção

Sem dados

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados